[12]
Musiliyu A, Musaa M, Omar F, Khanb JSC. Synthesis and antiproliferative activity of coumarin-estrogen conjugates against breast cancer cell lines. Lett Drug Des Discov 2012; 76: 211-20.
[33]
Zarrizi R, Menard J, Belting M, Massoumi R. Deubiquitination of γ -tubulin by BAP1 prevents chromosome instability in breast cancer cells. Cancer Res 2014; 0221-27.
[56]
Gary DJ, Gordon WG, Miles PH. Potential DNA bis-intercalating agents: Synthesis and antitumor activity of novel, conformationally restricted bis(9-Aminoacridine). J Het Chem 1987; 24: 1405-8.
[58]
Kalirajan R. Mohammed Rafick MH, Sankar S, Gowramma B. Green synthesis of some novel chalcone and isoxazole substituted 9-anilinoacridine derivatives and evaluation of their antimicrobial and larvicidal activities. Indian J Chem 2018; 57B: 583-90.
[65]
Sondhi SM, Johar M, Nirupama S, Sukla R, Raghubir R, Dastidar SG. Synthesis of sulpha drug acridine derivatives and their evaluation for anti-anflammatory, analgesic and anticancer activity. Indian J Chem 2002; 41B: 2659-66.
[71]
Hemalatha V, Sakila L, Balaji M. Molecular modelling and insilico drug docking studies on breast cancer target protein (TNRC9) using cheminformatics software and tools. Int J Novel Trends Pharm Sci 2015; 5(3): 55-63.
[75]
Kalirajan R, Sivakumar SU, Jubie S, Gowramma B, Suresh B. Synthesis and biological evaluation of some heterocyclic derivatives of chalcones. Int J Chem Sci 2009; 1(1): 27-34.
[79]
Kalirajan R. Microwave irradiated synthesis, characterization and evaluation for their antibacterial and larvicidal activities of some novel chalcone and isoxazole substituted 9-anilino Acridines. Open J Chem 2015; 1(1): 1-7.
[80]
Sahu S, Banerjee M, Sahu D, Behera C. Synthesis, analgesic and antimicrobial activities of some novel isoxazole derivatives. Dhaka Univ J Pharm Sci 2008; 7(1): 113-8.
[81]
Osama S, Moustafa S, Raga A. Synthesis and antimicrobial activity of some new cyanopyrimidines, isoxazoles, pyrazoles and pyrimidines bearing sulfonamide moiety Phosphorus Sulfur 2003 178: 475-84.
[85]
Kalirajan R, Leela R, Jubie S, Gowramma B, Gomathy S, Sankar S. Microwave assisted synthesis of some novel pyrazole substituted benzimidazoles and evaluation of their biological activities. Indian J Chem 2011; 50B: 1794-801.
[87]
Kalirajan R, Gowramma B, Jubie S, Sankar S. Molecular docking Studies and in silico ADMET Screening of some novel heterocyclic substituted 9-anilinoacridines as topoisomerase ii inhibitors. JSM Chem 2017; 5(1): 1039-44.
[89]
Gowramma B, Praveen TK, Gomathy S, Kalirajan R, Babu B, Nagappan K. Synthesis of 2-(Bis (2-Chloroethyl) Amino)-N- (5-substituedphenyl)-1,3,4- Thiadiazol- 2-Yl) Aceto hydrazide and Evaluation of Anticancer activity. Curr Bioact Compd 2018; 14(3): 309-16.
[91]
kalirajan R, Rathire L, Jubie S, et al. Microwave assisted synthesis and biological evaluation of pyrazole derivatives of benzimidazoles. Indian J Pharm Educ Res 2010; 44(4): 358-62.
[92]
Kalirajan R. Chitra, Jubie S, Gowramma B. Synthesis and biological evaluation of Mannich bases of 2-substituted Benzimidazoles. Asian J Chem 2009; 21(7): 5207-11.
[96]
Kalirajan R, Pandiselvi A, Gowramma B. In-silico drug design by docking studies, admet screening, mm-gbsa binding free energy of some chalcone substituted 9-anilinoacridines as her2 inhibitors targeting breast cancer. Int J Comp Theo Chem 2019; 7(1): 6-13.
[100]
Kalirajan R, Pandiselvi A, Sankar S, Gowramma B. Molecular docking studies and in silico ADMET screening of some novel chalcone substituted 9-anilinoacridines as topoisomerase ii inhibitors. SF J Pharm Anal Chem 2018; 1(1): 1004-9.
[101]
Reetu VK. Computer aided design of selective calcium channel blockers: Using pharmacophore - Based and docking simulations. Indian J Pharm Sci Res 2012; 3(3): 805-10.
[102]
Furrer D. Claudie Paquet, Simon Jacob, Caroline Diorio. Cancer prognosis 2018.
[103]
Pal S. An in silico drug designing approach to target the BRCA1 protein involved in breast cancer. Helix 2016; 16(1): 761-5.
[104]
Mehta S, Seema R. Pathak. In silico drug design and molecular docking studies of novel coumarin derivatives as anticancer agents. Asian J Pharm Clin Res 2017; 10(4): 335-40.
[105]
Sahu M, Amit GN. In silico design, synthesis and pharmacological screening of some Quinazolinone metal complexes as dihydrofolate reductase inhibitors for anticancer activity: Part-II. Int J Pharm Pharm Sci 2014; 6(5): 509-14.
,
Arumugasamy Pandiselvi,
Byran Gowramma and
Pandiyan Balachandran
Download PDF Flyer